Gene Activation
The efficacy of interferon against hepatitis C virus relies on STAT3 signaling
Published in Hepatitis Weekly, June 30th, 2003
According to a study from the United States, "interferon alfa (IFN-alpha)-based treatment is the only therapeutic option for chronic hepatitis C viral infection. However, the molecular mechanisms of IFN-alpha antiviral activity are not completely understood. The recent development of an HCV replicon cell culture system provides a feasible experimental model to investigate the molecular details of IFN-induced direct antiviral activity in hepatocytes."
"In this report, we show that IFN-alpha can effectively inhibit HCV subgenomic RNA replication and suppress viral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-06-30)
More Articles from Hepatitis Weekly
- Kidney Transplantation
Hepatitis C virus infection doesn't alter survival in renal transplant patients - Virology
HIV infection accelerates liver fibrosis in those coinfected with hepatitis C - Hepatitis C Therapy
ALT remission after HCV treatment relates to sustained biochemical response - Liver Transplantation
Advancing donor age impacts outcomes in HCV-positive liver recipients - Liver Transplantation
Eosinophilia counts have limitations as liver graft rejection screening tools - Oncology
Serum KL-6 has clinical significance in patients with chronic hepatitis C - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
